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Joint effectsn that they are caused by the joint action of multiple factors, both genetic and
environmental. Over the past few decades, the mathematical convenience of logistic regression has served to
enshrine the multiplicative model, to the point where many epidemiologists believe that departure from
additivity on a log scale implies that two factors interact in causing disease. Other terminology in
epidemiology, where students are told that inequality of relative risks across levels of a second factor should
be seen as “effect modiﬁcation,” reinforces an uncritical acceptance of multiplicative joint effect as the
biologically meaningful no-interaction null. Our ﬁrst task, when studying joint effects, is to understand the
limitations of our deﬁnitions for “interaction,” and recognize that what statisticians mean and what
biologists might want to mean by interaction may not coincide. Joint effects are notoriously hard to identify
and characterize, even when asking a simple and unsatisfying question, like whether two effects are log-
additive. The rule of thumb for such efforts is that a factor-of-four sample size is needed, compared with that
needed to demonstrate main effects of either genes or exposures. So strategies have been devised that focus
on the most informative individuals, either through risk-based sampling for a cohort, or case–control
sampling, extreme phenotype sampling, pooling, two-stage sampling, exposed-only, or case-only designs.
These designs gain efﬁciency, but at a cost of ﬂexibility in models for joint effects. A relatively new approach
avoids population controls by genotyping case–parent triads. Because it requires parents, the method works
best for diseases with onset early in life. With this design, the role of autosomal genetic variants is assessed
by in effect treating the nontransmitted parental alleles as controls for affected offspring. Despite advantages
for looking at genetic effects, the triad design faces limitations when examining joint effects of genetic and
environmental factors. Because population-based controls are not included, main effects for exposures
cannot be estimated, and consequently one only has access to inference related to a multiplicative null. We
have proposed a hybrid approach that offers the best features of both case–parent and case–control designs.
Through genotyping of parents of population-based controls and assuming Mendelian transmission, power is
markedly enhanced. One can also estimate main effects for exposures and now ﬂexibly assess models for
joint effects.
Published by Elsevier Inc.What is biological versus statistical interaction? Most diseases are
“complex” in that they are caused by the joint action of multiple
genetic and environmental (including lifestyle) factors, playing out
over age and time. The most interesting etiologic questions for
complex diseases bear on possibly shared pathways, co-regulated
families of genes, and the mechanisms by which genetic and
environmental factors modulate speciﬁc biologic processes. Methods
to characterize joint effects on susceptibility to complex diseases
should ideally illuminate the causal processes themselves, at
mechanistic levels of understanding.
Investigators, however, have a natural preference for problems
they can solve, and approaches to studying interactions haveof Public Health, October 2007.
nc.historically focused on speciﬁc statistical models. We begin by brieﬂy
considering the differences between how a biologist might think
about interaction and how a statistician might operationally deﬁne it.
Colloquially, people refer to two factors as behaving in a synergistic
way if their combined effect is greater than what would be expected
based on their individual separate effects. A classic example is
retardation due to phenylketonuria (PKU): dietary phenylalanine is
innocuous in the absence of the metabolic PKU genetic defect, and the
defect does not cause retardation in the absence of dietary
phenylalanine. (Hence the importance of neonatal screening for this
genetic variant.) Most synergistic interactions are less “pure” than the
PKU paradigm, and typically both factors individually cause some
increase in risk. Consequently, to say that a joint effect exceeds what
would be expected based on individual effects, we ﬁrst need a way to
form a reasonable expectation for their joint effect, against which to
deﬁne interaction, or synergism. Any deﬁnition of interaction logically
relies on some speciﬁcation of noninteractive effects.
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For assessing toxic effects of mixtures, toxicologists developed the
notion of “simple independent action (SIA)” [1]. The idea there was
probabilistic independence. If there is nobackground risk, that is, no risk in
the absence of either exposure A or B, then the probability of avoiding an
outcome, say D, when exposed to both A and B should be the product of
the two separate avoidance probabilities. Under simple independent
action, the risk factors A and B thus behave in a way that is mutually
oblivious. A paradigm for this would be two duck hunters separately
shooting at the same duck [2], where the duck must avoid the bullets
coming from both. Violations of SIA would then indicate nonindepen-
dence,whichwould be seen as synergy if the violation is in the direction of
increased risk and antagonism if in the direction of reduced risk. An
independently acting background cause (or aggregation of causes not
including A or B) can be allowed for as yet another independently
operating factor, so that if Pr[D|A,B] is the probability of D in the presence
of both exposures, simple independent actionwould require
Pr DjA;B 
Pr DjA;B
h i ¼
Pr DjA;B Pr DjA;B
h i
Pr DjA;B
h i
Pr DjA;B
h i ;
where the overbar indicates nonoccurrence of the exposure or
outcome. The idea again is that the probability of escaping the causes
associated with A, with B, and with the background factors is the
product of the three separate escape probabilities if A and B act
independently of each other and of all other unmeasured causal
factors (background). Taking logarithms yields amodel that is additive
in the log complement, adjusted by the background:

ln 1−Pr DjA;B½ ð Þ−lnð1−Pr½DjA;BÞ
¼ ln 1−Pr½DjA;B −lnð1−Pr½DjA;BÞ
þ lnð1−Pr½DjA;BÞ−lnð1−Pr½DjA;BÞ
Suppose D is rare, with risk near 0. Then, because mathematically
-ln(1 - x) converges to x as x goes to 0, this condition is approximately
the same as

Pr DjA;B½ −Pr½DjA;B ¼ Pr DjA;B −Pr½DjA;B
þ Pr½DjA;B−Pr½DjA;B;
that is, additivity on the absolute risk scale. Even if D is not rare, if one is
looking at hazards across instantaneous time the event is rare in each
small time interval. Thus, if λAB(t) is the instantaneous hazard rate at
time t for those exposed to both A and B, then noninteraction would
correspond to
λAB tð Þ−λAB tð Þ
  ¼ λAB tð Þ−λAB tð Þ
 þ λAB tð Þ−λAB tð Þ
 
;
that is, additivity of hazards. This additivity then corresponds to a
multiplicative model in cumulative survival. The notion here, biologi-
cally, might be that these two exposures act through completely
disjoint biologic pathways.
Epidemiologists, for reasons that are primarily historical andmathe-
matical, have instead preferred a model for statistical independence
that is based on additivity on a logarithmic scale applied to risk, rather
than 1 - risk. The multiplicative model for independence speciﬁes that
Pr½DjA;B
Pr½DjA;B ¼
Pr½DjA;BPr½DjA;B
Pr½DjA;BPr½DjA;B
that is, the relative risk associated with the combined exposure is the
product of the two relative risks. Another way to think of this is that
the relative risk for A relative to non-A (or B relative to non-B) is the
same across levels of B (or A). If the disease is rare in the population
under study, then the above model is approximately equivalent to a
multiplicative model for the odds ratios, which becomes additivity on
¼ ln 1−Pr½DjA;B −lnð1−Pr½DjA;BÞthe logistic scale. In an unfortunate use of terminology, epidemiolo-
gists refer to departures from this model as effect modiﬁcation, a jargon
that strongly implies that one factor modiﬁes the effect of the other. (A
recent advance is instead to use the phrase effect-measure modiﬁcation
[3].)
Thus, there are a number of different possible scales on which to
deﬁne noninteraction; although the biologist may prefer the log-
complement scale because of the natural interpretability of probabil-
istic independence, the epidemiologist has traditionally preferred the
log-odds scale. In practice, this distinctionmay not be a subtle one. For
example, suppose the background risk (i.e., the risk in those with
neither A nor B) is 10 per 100,000, whereas the risk with A alone is 20
per 100,000 and the risk with B alone is 30 per 100,000. Then if the
risk in those with both is 50 per 100,000, there is antagonism
(competition?) between A and B under a log-odds null, but synergism
(enhancement?) under a log-complement null, because the expecta-
tion under the former is 60 per 100,000, versus 40 per 100,000 under
the latter. Thus, under onemodel the two exposuresmutually enhance
each other, and under the other they are seen as working against each
other. So the direction of the ﬁnding can be different, depending on
the selected model for nonindependence. Another consideration is
that power for detecting “interaction” can be markedly greater if the
null is speciﬁed additively. This enhancement of statistical power
happens, not for some subtle reason, but simply because super-
multiplicative joint action of two risk-enhancing factors is more
distant from an additive null than from a multiplicative null.
Even under the simple log-odds formulation, detection of interac-
tions tends to be statistically challenging, and a rule of thumb has been
that the sample size required is about fourfold what would be needed
to detect a main effect of similar magnitude. Thus, a doubling of a
relative risk from one stratum to another is about four times as hard to
detect as a twofold relative risk.
Less-is-more approaches
Epidemiologic designs have been developed to extract more
information from fewer people by judicious sampling strategies. Two-
stage sampling, for example, was developed as a strategy for situations
where a rare exposure is under study, and one can improve efﬁciency
dramatically, particularly for studying interactions, by oversampling
exposed cases and exposed controls and adjusting for the covariate-
and outcome-dependent sampling fractions in the analysis [4,5]. Pooling
of specimens is another strategy that has been proposed as a way to
include many more study subjects by minimizing assay costs, when
interaction is of interest and exposure is assessed by a biomarker [6].
The case-only design is an extreme form of a less-is-more strategy,
because no controls are sampled at all [7]. In place of controls we make a
strong assumption. If one can safely assume that factors A and B occur
independently of each other in the source population (an assumption that
may often hold with an environmental factor and a genetic variant), then
one can test a multiplicatively deﬁned interaction using only cases.
Reiterating the argument given by Piegorsch et al. [7], this can be seen as
follows. Consider the multiplicative interaction parameter:
ψ ¼ Pr DjA;B½ Pr½DjA;B
Pr½DjA;BPr½DjA;B
Under the null that the joint effect of A together with B is simply
multiplicative, this parameter is 1. Algebraically, it can be reexpressed as
follows:
Pr½A;BjDPr½A;BjD
Pr½A;BjDPr½A;BjD=
Pr½A;BPr½A;B
Pr½A;BPr½A;B
Now note that under independence of A and B in the source
population, the ratio in the denominator is 1 and what is left is the
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The remarkable feature of this design is that its efﬁciency for detecting
departures frommultiplicative joint effects is as good as that of a study
with an inﬁnitely large control group, because in effect the controls
are serving only to estimate that denominator “1” with increasing
precision. However, the user should beware, because the limitations
are drastic for the case-only design: even when the primary
assumption holds, main effects cannot be studied at all and only
multiplicative interactions can be assessed. Often a genetic factor and
an environmental factor will not occur independently in the
population, violating the method's primary assumption, because
attrition of risk factors can be jointly selective. These constraints
handicap case-only inference related to joint effects.
A relatively new design also avoids use of population-based
controls, but uses as genetic controls the parents of cases, who are
ethnically matched to each case [8]. One studies triads consisting of
affected individuals and their parents. The notion is that genetic
variants that confer susceptibility will have been over-transmitted to
people with disease (compared with Mendelian transmission), and
the extent of that over-transmission allows us to estimate the genetic
relative risks [9]. This approach offers robustness against the bias due
to population stratiﬁcation that can affect a case-control approach to
studying genetic risk factors. It also allows detection of maternally
mediated genetic effects [10] and parent-of-origin effects [11].
Stratiﬁcation on exposure also permits estimation of multiplicative
interaction parameters, by testing whether the genetic relative risks
are the same across levels of the exposure. Clearly, this design relies on
the adequate availability of parents and is best if used for conditions
with onset early in life, such as birth defects. Although genetic main
effects can now be estimated, a limitation is that because one cannot
estimate the main effects of exposures with this design, one can work
only with a multiplicative formulation for joint effects, and conse-
quently sacriﬁces ﬂexibility in inference.
A promising extension of the case-parent design, originally
proposed by Nagelkerke et al., incorporates some controls from the
population, as a kind of hybrid between the case-control and the case-
parent triad approach [12]. In a recent variant of this design [13], the
exposures for controls are studied, but one genotypes the parents of
controls and not the controls themselves. The inclusion of control
parents allows one to capture information related to enrichment for
causative alleles in the parents of cases compared with parents of
controls, information that is sacriﬁced by triad methods, which
condition on the parental genotypes. The inclusion of controls greatly
enhances the power of the design for detecting genetic effects. There
are also advantages for studying gene-by-environment interaction.Provided one can safely assume Mendelian transmission, nondiffer-
ential survival (vis-à-vis the gene) to the age at study, and absence of
bias due to genetic population stratiﬁcation, this hybrid approach now
allows estimation of the main effects of exposures, as well as the main
effects of autosomal genetic variants, and hence provides both
improved power and enhanced ﬂexibility for modeling joint effects
of genetic and environmental factors. Despite such advances,
characterization of joint gene-gene effects and joint effects of genetic
and environmental factors will continue to present a challenge.
Methodologic research for studying the etiology of complex diseases
remains in its infancy, both conceptually and practically.
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